Medico Remedies Limited (MEDICO.NS)
INR 51.12
(2.22%)
INR 51.12
(2.22%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 163.37 Million INR | -17.06% |
| 2022 | 196.98 Million INR | 8.77% |
| 2021 | 181.1 Million INR | 24.46% |
| 2020 | 145.51 Million INR | -20.31% |
| 2019 | 182.59 Million INR | 13.62% |
| 2018 | 160.7 Million INR | 7.78% |
| 2017 | 149.1 Million INR | 47.0% |
| 2016 | 101.43 Million INR | 10.62% |
| 2015 | 91.69 Million INR | 12.23% |
| 2014 | 81.7 Million INR | 7.22% |
| 2013 | 76.2 Million INR | 64.92% |
| 2012 | 46.2 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 163.37 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 163.37 Million INR | -17.06% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 157.98 Million INR | 0.0% |
| 2022 Q2 | 220.85 Million INR | 0.0% |
| 2022 FY | 196.98 Million INR | 8.77% |
| 2022 Q4 | 196.98 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 FY | 181.1 Million INR | 24.46% |
| 2021 Q4 | 181.1 Million INR | 0.0% |
| 2021 Q2 | 160.32 Million INR | 0.0% |
| 2020 Q3 | 145.5 Million INR | 1.19% |
| 2020 Q1 | 143.78 Million INR | -21.26% |
| 2020 Q4 | 145.51 Million INR | 0.01% |
| 2020 Q2 | 143.78 Million INR | 0.0% |
| 2020 FY | 145.51 Million INR | -20.31% |
| 2019 Q1 | 136.03 Million INR | -15.35% |
| 2019 FY | 182.59 Million INR | 13.62% |
| 2019 Q4 | 182.59 Million INR | 0.0% |
| 2019 Q3 | 182.59 Million INR | 34.23% |
| 2019 Q2 | 136.03 Million INR | 0.0% |
| 2018 Q1 | 149.45 Million INR | 0.24% |
| 2018 FY | 160.7 Million INR | 7.78% |
| 2018 Q4 | 160.7 Million INR | 0.0% |
| 2018 Q3 | 160.7 Million INR | 7.53% |
| 2018 Q2 | 149.45 Million INR | 0.0% |
| 2017 FY | 149.1 Million INR | 47.0% |
| 2017 Q1 | 116.85 Million INR | 15.2% |
| 2017 Q2 | 116.85 Million INR | 0.0% |
| 2017 Q3 | 149.1 Million INR | 27.6% |
| 2017 Q4 | 149.1 Million INR | 0.0% |
| 2016 Q4 | 101.43 Million INR | 0.0% |
| 2016 FY | 101.43 Million INR | 10.62% |
| 2015 FY | 91.69 Million INR | 12.23% |
| 2014 FY | 81.7 Million INR | 7.22% |
| 2013 FY | 76.2 Million INR | 64.92% |
| 2012 FY | 46.2 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Sigachi Industries Limited | 707.2 Million INR | 76.899% |
| Ind-Swift Limited | 640.91 Million INR | 74.51% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 88.658% |
| Sakar Healthcare Limited | 277.32 Million INR | 41.09% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.833% |
| Innova Captab Limited | 1.44 Billion INR | 88.656% |
| Divi's Laboratories Limited | 31.84 Billion INR | 99.487% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 92.831% |
| Morepen Laboratories Limited | 2.48 Billion INR | 93.428% |
| Mankind Pharma Limited | 15.53 Billion INR | 98.948% |
| Sequent Scientific Limited | 3.46 Billion INR | 95.281% |
| Wanbury Limited | 360.23 Million INR | 54.648% |
| Laurus Labs Limited | 18.45 Billion INR | 99.115% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 97.696% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 97.549% |
| Alembic Limited | 113.4 Million INR | -44.067% |
| Hikal Limited | 3.03 Billion INR | 94.621% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.006% |
| Neuland Laboratories Limited | 3.5 Billion INR | 95.338% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 96.749% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.35% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 96.155% |
| Themis Medicare Limited | 705.74 Million INR | 76.851% |
| RPG Life Sciences Limited | 1.01 Billion INR | 83.825% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 99.525% |
| Lupin Limited | 49.53 Billion INR | 99.67% |
| Amrutanjan Health Care Limited | 289.04 Million INR | 43.479% |
| Wockhardt Limited | 6.4 Billion INR | 97.447% |
| Vaishali Pharma Limited | 3.79 Million INR | -4202.66% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 97.459% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -8.936% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 98.733% |
| FDC Limited | 3.88 Billion INR | 95.799% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.743% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -309.659% |
| Eris Lifesciences Limited | 1.89 Billion INR | 91.357% |
| Venus Remedies Limited | 1.21 Billion INR | 86.575% |
| ZIM Laboratories Limited | 812.62 Million INR | 79.896% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 86.207% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -291.123% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | 95.5% |
| Shilpa Medicare Limited | 3.44 Billion INR | 95.264% |
| Albert David Limited | 436.12 Million INR | 62.54% |
| Ajanta Pharma Limited | 8.28 Billion INR | 98.028% |
| Hester Biosciences Limited | 755.81 Million INR | 78.385% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 92.934% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 95.458% |
| Gufic Biosciences Limited | 2 Billion INR | 91.851% |
| Windlas Biotech Limited | 621.89 Million INR | 73.73% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 85.027% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | 52.886% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 86.786% |
| Granules India Limited | 13 Billion INR | 98.744% |
| Aarti Drugs Limited | 4.85 Billion INR | 96.638% |
| Bal Pharma Limited | 878.11 Million INR | 81.395% |
| Alkem Laboratories Limited | 26.61 Billion INR | 99.386% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.834% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | 78.829% |
| Medicamen Biotech Limited | 593.75 Million INR | 72.485% |
| Unichem Laboratories Limited | 7.04 Billion INR | 97.682% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | 44.885% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -540.75% |
| Valiant Laboratories Limited | 100.15 Million INR | -63.121% |
| Orchid Pharma Limited | 2.64 Billion INR | 93.817% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -56.222% |
| Ipca Laboratories Limited | 24.71 Billion INR | 99.339% |
| Brooks Laboratories Limited | 96.1 Million INR | -69.988% |
| Syncom Formulations (India) Limited | 210.81 Million INR | 22.505% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.283% |
| NATCO Pharma Limited | 7 Billion INR | 97.668% |
| Suven Life Sciences Limited | 7.08 Million INR | -2205.886% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -66.767% |
| Strides Pharma Science Limited | 11.26 Billion INR | 98.549% |
| Indoco Remedies Limited | 3.53 Billion INR | 95.373% |
| Alpa Laboratories Limited | 136.65 Million INR | -19.552% |
| Lasa Supergenerics Limited | 190.43 Million INR | 14.211% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -1004.462% |